ClinConnect ClinConnect Logo
Search / Trial NCT01044732

Third Eye Retroscope Randomized Clinical Evaluation

Launched by AVANTIS MEDICAL SYSTEMS · Jan 6, 2010

Trial Information

Current as of June 01, 2025

Completed

Keywords

Colorectal Neoplasms Adenomas Polyps Miss Rates Detection Rates Colonoscope Third Eye Retroscope

ClinConnect Summary

Colonoscopy is generally agreed to be the best method for detecting and removing pre-cancerous polyps, but some lesions can be missed, especially if they are located behind folds in the lining of the colon or behind flexures (sharp bends) in the colon.

The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon. Previous studies have shown the device to be effective for detecting additional polyps that could not have been...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
  • The patient must understand and provide written consent for the procedure.
  • Exclusion Criteria:
  • Patients with a history of colonic resection;
  • Patients with inflammatory bowel disease;
  • Patients with a personal history of polyposis syndrome;
  • Patients with suspected chronic stricture potentially precluding complete colonoscopy;
  • Patients with diverticulitis or toxic megacolon;
  • Patients with a history of radiation therapy to abdomen or pelvis;
  • Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.

About Avantis Medical Systems

Avantis Medical Systems is a pioneering clinical trial sponsor dedicated to advancing the field of medical technology through innovative solutions for gastrointestinal procedures. With a strong focus on developing cutting-edge endoscopic devices, the company aims to enhance patient outcomes and streamline clinical workflows. Leveraging a robust research framework and a commitment to quality, Avantis collaborates with healthcare professionals to conduct rigorous clinical trials that assess the safety and efficacy of its products. Through these efforts, the company strives to address unmet medical needs and contribute to the evolution of minimally invasive treatments in gastroenterology.

Locations

Lebanon, New Hampshire, United States

Dallas, Texas, United States

Utrecht, , Netherlands

Baltimore, Maryland, United States

Kansas City, Missouri, United States

Providence, Rhode Island, United States

Brussels, , Belgium

Milan, , Italy

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Peter D. Siersema, MD, PhD

Principal Investigator

UMC Utrecht

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials